No Data
No Data
No Data
No Data
No Data
Belite Bio Is Maintained at Buy by HC Wainwright & Co.
Belite Bio Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 22 11:23 ET
Express News | HC Wainwright & Co. Maintains Buy on Belite Bio, Maintains $59 Price Target
Moomoo 24/7Mar 22 11:13 ET
Buy Rating Affirmed on Belite Bio as Tinlarebant Shows Promising Clinical Advancements and Market Potential
TipRanksMar 22 09:25 ET
Belite Bio Advances Retinal Disease Treatment
TipRanksMar 22 08:27 ET
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
Tinlarebant is Belite Bio's orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration
GlobeNewswireMar 22 08:00 ET
Buy Rating Justified for Belite Bio, Inc. ADR Amidst Promising DRAGON Trial Progress and Strong Financials
TipRanksMar 21 02:16 ET
No Data
No Data